Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04802733 |
|---|---|
| Brief Title: | Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease |
| First Submitted : | March 12, 2021 |
| First Submitted that Met QC Criteria : | March 15, 2021 |
| First Posted : | March 17, 2021 |
| Last Update Submitted that Met QC Criteria : | May 31, 2022 |
| Last Update Posted : | June 2, 2022 |